225 related articles for article (PubMed ID: 31164632)
1. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
[TBL] [Abstract][Full Text] [Related]
2. LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression.
Liao C; Long Z; Zhang X; Cheng J; Qi F; Wu S; Huang T
Int J Biol Sci; 2020; 16(1):1-11. PubMed ID: 31892841
[TBL] [Abstract][Full Text] [Related]
3. MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
Xu M; Li J; Wang X; Meng S; Shen J; Wang S; Xu X; Xie B; Liu B; Xie L
Cell Death Dis; 2018 Feb; 9(2):209. PubMed ID: 29434190
[TBL] [Abstract][Full Text] [Related]
4. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
5. miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
Huang J; Wang B; Hui K; Zeng J; Fan J; Wang X; Hsieh JT; He D; Wu K
Oncol Rep; 2016 Sep; 36(3):1693-701. PubMed ID: 27430302
[TBL] [Abstract][Full Text] [Related]
6. The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.
Huang J; Zhou W; Hao C; He Q; Tu X
PLoS Genet; 2022 Oct; 18(10):e1010366. PubMed ID: 36288387
[TBL] [Abstract][Full Text] [Related]
7. IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.
Lo UG; Pong RC; Yang D; Gandee L; Hernandez E; Dang A; Lin CJ; Santoyo J; Ma S; Sonavane R; Huang J; Tseng SF; Moro L; Arbini AA; Kapur P; Raj GV; He D; Lai CH; Lin H; Hsieh JT
Cancer Res; 2019 Mar; 79(6):1098-1112. PubMed ID: 30504123
[TBL] [Abstract][Full Text] [Related]
8. Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.
Qiu F; Liu Q; Xia Y; Jin H; Lin Y; Zhao X
J Exp Clin Cancer Res; 2022 Jan; 41(1):22. PubMed ID: 35031054
[TBL] [Abstract][Full Text] [Related]
9. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
[TBL] [Abstract][Full Text] [Related]
10. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
11. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer.
Li J; Xu X; Meng S; Liang Z; Wang X; Xu M; Wang S; Li S; Zhu Y; Xie B; Lin Y; Zheng X; Liu B; Xie L
Cell Death Dis; 2017 Aug; 8(8):e3010. PubMed ID: 28837140
[TBL] [Abstract][Full Text] [Related]
12. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
[TBL] [Abstract][Full Text] [Related]
13. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
Wang S; Zhang G; Zheng W; Xue Q; Wei D; Zheng Y; Yuan J
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352837
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition.
Li Y; Wan B; Liu L; Zhou L; Zeng Q
Biochem Biophys Res Commun; 2019 Jan; 508(4):991-996. PubMed ID: 30551873
[TBL] [Abstract][Full Text] [Related]
15. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
16. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.
Xu X; Zhu Y; Liang Z; Li S; Xu X; Wang X; Wu J; Hu Z; Meng S; Liu B; Qin J; Xie L; Zheng X
Cell Death Dis; 2016 Feb; 7(2):e2088. PubMed ID: 26844702
[TBL] [Abstract][Full Text] [Related]
17. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
19. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
